```html

Quinine‑Induced Thrombocytopenia

What is Quinine‑Induced Thrombocytopenia?

Quinine‑induced thrombocytopenia is an immune‑mediated drop in platelet count that occurs after exposure to quinine, a medication historically used to treat malaria and, more commonly today, to relieve nocturnal leg cramps. In susceptible individuals, quinine acts as a hapten, binding to platelet surface proteins and prompting the immune system to produce antibodies that destroy platelets. The result is thrombocytopenia—typically defined as a platelet count < 150 × 10⁹/L—which can lead to easy bruising, bleeding, and, in severe cases, life‑threatening hemorrhage.

Although quinine is generally safe when taken in low doses, drug‑dependent immune thrombocytopenia is rare but well‑documented (≈1 per 20,000 exposures). It may develop after a single dose or after repeated use, and symptoms usually appear within days to a few weeks of taking the drug.

Common Causes

Quinine‑induced thrombocytopenia is a specific type of drug‑dependent immune thrombocytopenia (DIT). Below are the most frequent precipitants, grouped by drug class or exposure:

• Quinine (prescription and over‑the‑counter) – the primary trigger.
• Quinidine (anti‑arrhythmic related to quinine).
• Other quinoline antimalarials (e.g., mefloquine, chloroquine) – less common but reported.
• Antibiotics with quinoline structure (e.g., ciprofloxacin – rare cross‑reactivity).
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – can cause a similar immune response.
• Heparin (including low‑molecular‑weight heparin) – causes heparin‑induced thrombocytopenia (HIT) which is mechanistically different but clinically overlaps.
• Glycoprotein IIb/IIIa inhibitors (e.g., abciximab).
• Antiepileptics (e.g., carbamazepine, phenytoin).
• Sulfonamide antibiotics (e.g., trimethoprim‑sulfamethoxazole).
• Vitamin K antagonists (e.g., warfarin) – rarely associated with immune thrombocytopenia.

Associated Symptoms

Platelets are essential for normal blood clotting. When their numbers fall, patients may notice the following signs, often in combination with a recent quinine exposure:

• Unexpected bruising (purpura) on the arms, legs, or torso.
• Petechiae – tiny red or purple spots 1–2 mm in diameter, most often on the lower legs.
• Nosebleeds (epistaxis) that last longer than usual.
• Bleeding gums or prolonged bleeding after dental work.
• Heavy or prolonged menstrual bleeding (menorrhagia).
• Blood in urine (hematuria) or stool (melena) indicating gastrointestinal bleeding.
• Easy bleeding from minor cuts or scrapes.
• Fatigue or light‑headedness due to mild anemia secondary to chronic micro‑bleeding.

When to See a Doctor

Because the condition can progress quickly, prompt medical evaluation is essential if you notice any of the following after using quinine (including over‑the‑counter leg‑cramp tablets):

• New bruises or petechiae without a clear cause.
• Nosebleeds that do not stop after 10–15 minutes.
• Bleeding that lasts > 5 minutes after a minor cut.
• Sudden, heavy menstrual bleeding (changing pads/tampons every hour).
• Blood in urine or stool.
• Unexplained fatigue or shortness of breath with evidence of bleeding.
• Any sign of internal bleeding (abdominal pain, coughing up blood, vomiting blood).

Diagnosis

Diagnosing quinine‑induced thrombocytopenia involves a blend of clinical history, laboratory testing, and exclusion of other causes.

1. Detailed Medication History

The clinician will ask specifically about quinine use—dose, formulation (prescription tablet, “leg‑cramp” product), and timing relative to symptom onset.

2. Complete Blood Count (CBC) with Peripheral Smear

A low platelet count (< 150 × 10⁹/L) confirms thrombocytopenia. The smear helps rule out platelet clumping, pseudothrombocytopenia, or bone‑marrow disorders.

3. Exclusion of Other Causes

• Viral infections (e.g., HIV, hepatitis C, EBV, CMV).
• Autoimmune diseases (systemic lupus erythematosus, ITP).
• Bone‑marrow infiltration or failure.
• Heparin exposure (HIT testing with PF4‑ELISA).

4. Quinine‑Dependent Platelet Antibody Test

Specialized labs (often reference centers) can perform a flow‑cytometry or ELISA assay that detects antibodies binding to platelets only in the presence of quinine. A positive result strongly supports the diagnosis.

5. Additional Studies (if needed)

• Coagulation profile (PT/INR, aPTT) – usually normal.
• Liver and kidney function tests to assess organ involvement.

Treatment Options

Management focuses on stopping the offending agent and supporting platelet recovery.

1. Immediate Discontinuation of Quinine

All quinine‑containing products must be stopped. Even a single dose may have triggered the reaction, so future exposure should be avoided indefinitely.

2. Observation & Supportive Care

• Most patients with platelet counts > 30 × 10⁹/L and no active bleeding can be observed with close follow‑up.
• Encourage a soft‑diet, avoid NSAIDs, and limit activities that could cause trauma.

3. Pharmacologic Interventions (for moderate‑severe cases)

• Corticosteroids – Prednisone 1 mg/kg daily for 5‑7 days, then taper. Helps dampen the immune response.
• Intravenous Immunoglobulin (IVIG) – 1 g/kg daily for 1‑2 days if rapid platelet rise is needed (e.g., before surgery or active bleeding).
• Anti‑D (Rhesus) immunoglobulin – for Rh‑positive, non‑splenectomized patients when steroids/IVIG are contraindicated.
• Platelet transfusion – reserved for life‑threatening hemorrhage; transfused platelets are often rapidly destroyed but still provide temporary hemostasis.

4. Management of Bleeding

• Topical hemostatic agents (e.g., tranexamic acid mouthwash) for dental or gum bleeding.
• Systemic tranexamic acid 10 mg/kg IV every 8 hours for severe mucosal bleeding (cautiously in patients with renal dysfunction).

5. Follow‑up

Platelet counts should be rechecked every 2‑3 days until they rise above 100 × 10⁹/L, then weekly for 4‑6 weeks to ensure no rebound.

Prevention Tips

• Avoid quinine‑containing products – read labels of over‑the‑counter “night‑time leg‑cramp” tablets, tonic water, and certain herbal teas.
• If you have a documented reaction, wear a medical alert bracelet stating “Quinine allergy – thrombocytopenia”.
• Inform all health‑care providers (dentist, pharmacist, surgeon) of the reaction.
• Consider alternative therapies for leg cramps, such as stretching, magnesium supplementation, or prescription muscle relaxants (after physician approval).
• Keep a medication list and review it before starting any new prescription or OTC drug.
• Pregnant women should avoid quinine unless specifically prescribed, as it crosses the placenta.
• Do not self‑prescribe quinine for malaria prophylaxis; use CDC‑recommended agents instead.

Emergency Warning Signs

If any of the following develop, seek emergency care (go to the nearest emergency department or call 911):

• Severe, uncontrolled bleeding (e.g., brain bleed symptoms: sudden severe headache, vision changes, loss of consciousness).
• Bleeding that does not stop after applying firm pressure for 10 minutes.
• Blood in the urine or stool accompanied by abdominal pain.
• Sudden drop in blood pressure, rapid heart rate, or fainting.
• Unexplained severe fatigue or shortness of breath with rapid heartbeat.

Key Take‑aways

Quinine‑induced thrombocytopenia is a rare but serious immune reaction that can cause dangerous bleeding. Early recognition—particularly after taking quinine for leg cramps or malaria—paired with prompt discontinuation of the drug and appropriate medical treatment usually leads to full recovery. Patients with a known reaction should permanently avoid quinine and notify all health‑care providers of the allergy.

References:

• Mayo Clinic. “Quinine side effects.” mayoclinic.org.
• CDC. “Malaria treatment guidelines – quinine use.” cdc.gov.
• NIH National Library of Medicine. “Drug‑induced immune thrombocytopenia.” pubmed.ncbi.nlm.nih.gov.
• Cleveland Clinic. “Thrombocytopenia causes and treatment.” my.clevelandclinic.org.
• World Health Organization. “Safety of quinine in pregnancy.” who.int.

```